Tolerability and efficacy of single dose diethylcarbamazine (DEC) alone or co-administration with Ivermectin in the clearance of Wuchereria bancrofti microfilaraemia in Pondicherry, South India

Journal of Communicable Diseases

Volumn 36, Issue 4, 2004, Pages 240-250

  Pani, S P ^a   Subramanyam Reddy, G ^b   Vanamail, P ^a   Venkatesvarlou, N ^b   Das, L K ^a   Vijayan, A P ^b  

^a VECTOR CONTROL RESEARCH CENTRE   (India)

^b Government General Hospital   (India)

Author keywords

Bancroftian filariasis; DEC; Efficacy; India; Ivermectin; Tolerability

Indexed keywords

ANTIFILARIAL AGENT; ANTIPARASITIC AGENT; DIETHYLCARBAMAZINE; IVERMECTIN;

ADOLESCENT; ADULT; ANIMAL; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG COMBINATION; DRUG EFFECT; FEMALE; HUMAN; INDIA; LYMPHATIC FILARIASIS; MALE; MICROFILARIA; PARASITEMIA; PARASITOLOGY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; WUCHERERIA BANCROFTI;

ADOLESCENT; ADULT; ANIMALS; ANTIPARASITIC AGENTS; DIETHYLCARBAMAZINE; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; ELEPHANTIASIS, FILARIAL; FEMALE; FILARICIDES; HUMANS; INDIA; IVERMECTIN; MALE; MICROFILARIA; PARASITEMIA; TREATMENT OUTCOME; WUCHERERIA BANCROFTI;

EID: 30944465199     PISSN: 00195138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Das PK and Pani SP. "Filariasis, Epidemiology and Control". In: Helminthology in India, 2002.
2. Ottesen EA, Duke BOL, Karam M and Behbehani K. Strategies and tools for the control/elimination of lymphatic filariasis. Bull WHO 1997; 75(6): 491-588.
3. Ministry of Health and Family Welfare: Government of India: National Health Policy 2002 [http://mohfw.nic.in/np2002.htm].
4. Kumaraswami V, Ottesen EA, Vijaysekharan V, Umadevi S, Swaminathan M, Aziz MA, et al. Ivermectin for the treatment of Wuchereria bancrofti filariasis: efficacy and adverse reactions. Journal of the American Medical Association 1988; 259: 3150-3153.
5. Reddy GS, Vengatesvarlou N, Das PK, Vanamail P, Vijayan AP, Sasi Kala, et al. Tolerability and efficacy of single dose Diethylcarbamazine (DEC) or Ivermectin in the clearance of Wuchereria bancrofti microfilaraemia at Pondicherry, south India. Tropical Medicine and International Health 2000; 5:(11): 779-785.
6. Shenoy RK, Kumarasami V, Rajan K, Thankom S and Jalajakumari. Ivermectin for the treatment of periodic Malayan filariasis: a study of efficacy and side effects following a single oral dose and retreatment at six months. Annals of Tropical Medicine and Parasitology 1992; 86: 271-278.
7. Moulia-Pelat JP, Glaziou O, Weil GJ, Nguyen LN, Gaxotte P and Nicholas L. Combination Ivermectin plus diethylcarbamazine, a new effective tool for control of lymphatic filariasis. Trop Med Parasitol 1995; 46: 9-12.
8. Shenoy RK, George LM, John A, Suma TK and Kumarasami V. Treatment of microfilaraemia in asymptomatic brugian filariasis: the efficacy and safety of the combination of single doses of ivermectin and diethylcarbamazine. Annals of Tropical Medicine and Parasitology 1998; 92: 579-585.
9. Ottesen EA, Vijaysekharan V, Kumaraswami V, Perumal Pillai SV, Sadanandam A, Frederick S, et al. A controlled trial of ivermectin and diethylcarbamazine in lymphatic filariasis. New England Journal of Medicine 1990; 322: 1113-1117.
10. Kar SK, Patnaik S, Kumaraswami V and Murty RS Adverse reactions following Ivermectin therapy in high density bancroftian microfilaraemics. Acta Trop 1993; 55: 21-31.
11. Das PK and Pani SP. Towards elimination of lymphatic filariasis in India: Problems, challenges, opportunities and new initiatives. The Journal of the International Medical Science Academy. 2000; 13: 18-26.
12. World Medical Association: Declaration of Helsinki - Recommendations guiding physicians in biomedical research involving human subjects. In: WHO Technical Report Series 1995; 850: 30-33 [http://www.who.int/medicines/library/ par/ggcp/GCPGuidePharmatrials.pdf].
13. World Health Organization: Guidelines for good clinical practice (GCP) for trials on pharmaceutical products. WHO Technical Report Series 1995; 850: 1-35 [http://www.who.int/medicines/library/par/ggcp/GCPGuidePharmatrials.pdf].
14. Indian Council of Medical Research: Statement of general principles on ethical considerations involving human subjects In: Ethical guidelines for biomedical research on human subjects 2000; 1-8.
15. Richards FO Jr, Eberhard ML, Bryan RT, McNeeley DF, Lammie PJ, McNeeley MB, et al. Comparison of high dose Ivermectin and diethylcarbamazine for activity against bancroftian filariasis in Haiti. Am J Trop Med Hyg 1991; 44: 3-10.
16. Addiss DG, Eberhard ML, Lammie PJ, McNeeley MB, Lee SH, McNeeley DF and Spencer HC. Comparative efficacy of clearing dose and single high-dose Ivermectin and diethylcarbamazine against Wuchereria bancrofti microfilaraemia. Am J Trop Med Hyg 1993; 48: 178-185.
17. Coutinho AD, Dreyer G, Medeiros Z, Lopes E, Machado G, Rizzo JA, et al. Ivermectin treatment of bancoftian filariasis in Recife, Brazil. Am J Trop Med Hyg 1994; 50: 339-48.
18. Moulia-Pelat JP, Nguyen LN, Hascoet H and Nicholas L. Combination of Ivermectin and diethylcarbamazine for improved control of lymphatic filariasis. Parasite 1996; 3: 45-48.
19. Youssef FG, Hassanein SH, Abdel-Fatah MS and El-Sharkawy IM. Effect of two single doses of Ivermectin in treatment of asymptomatic bancrofti filariasis in two villages in the Nile Delta, Egypt. J Egypt Soc Parasitol 1997; 27: 83-92.
20. Reuben R, Rajendran R, Sunish IP, Mani TR, Tewari SC, Hiriyan J, et al. Annual single dose diethylcarbamazine plus ivermectin for control of bancroftian filariasis: comparative efficacy with and without vector control. Annals of Tropical Medicine and Parasitology 2001; 95: (4) 361-378.
21. Das PK, Ramaiah KD, Vanamail P, Yuvraj J, Balarajan K and Bundy DAP. Placebo-controlled community trial of four cycles of single dose diethylcarbamazine or ivermectin against W. bancrofti infection and transmission in India. Trans Roy Soc Trop Med and Hyg 2001; 95: 336-341.
22. Rajendran R, Sunish IP, Mani TR, Tewari SC, Munirathinam A, Abdullah SM, et al. The influence of the mass administration of DEC, alone or with Albendazole, on the prevalence of antigenaemia. Annals of Tropical Medicine and Parasitology 2002; 965: (6) 595-602.